<PAGE>

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549


                                   FORM 10-QSB


                   QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


For Quarter ended May 31, 2008

Commission file number 2-92261


                           WESTBRIDGE RESEARCH GROUP
                           -------------------------

           California                                            95-3769474
---------------------------------                            -------------------
  (State or other jurisdiction                                (I.R.S. Employer
of incorporation or organization)                            Identification No.)


       1260 Avenida Chelsea
        Vista, California                                          92081
---------------------------------------                        -------------
(Address of principal executive office)                          (Zip Code)

Registrant's telephone number,
including area code:                                             (760) 599-8855
                                                                 --------------

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [ ]

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date: 2,103,438 shares of common stock, no
par value, as of May 31, 2008.

Transitional Small Business Disclosure Format (Check One) Yes [ ] No [X]

<PAGE>


CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS
----------------------------------------------------

      Certain statements contained in this report that are not historical facts
are forward-looking statements (within the meaning of Section 21E of the
Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933)
that are subject to certain risks and uncertainties that could cause actual
results to differ materially from those set forth in the forward-looking
statements. When we use the words "anticipates", "plans", "expects", "believes",
"should", "could", "may", and similar expressions, we are identifying
forward-looking statements. These risks and uncertainties include, but are not
limited to, a slow-down in the domestic or international markets for the
Company's products; greater competition for customers from businesses who are
larger and better capitalized; local, state, federal or international regulatory
changes which adversely impact the Company's ability to manufacture or sell its
products, particularly its organic products; the reliance of the Company on
limited sources of raw materials; an increase in the Company's costs of raw
materials.

      Except as may be required by applicable law, we do not undertake or intend
to update or revise our forward-looking statements, and we assume no obligation
to update any forward looking statements contained in this Quarterly Report on
Form 10-QSB as a result of new information or future events or developments. You
should not assume that our silence over time means that actual events are
bearing out as expressed or implied in such forward looking statements. You
should carefully review and consider the various disclosures we make in this
report and our other reports filed with the Securities and Exchange Commission
that attempt to advise interested parties of the risks, uncertainties and other
factors that may affect our business.

<PAGE>
<TABLE>
<S>            <C>
                         PART I - FINANCIAL INFORMATION

                          ITEM 1 - FINANCIAL STATEMENTS

                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY
                      CONSOLIDATED CONDENSED BALANCE SHEETS



                                                         MAY 31,      NOVEMBER 30,
                                                          2008           2007
                                                      (UNAUDITED)      (AUDITED)
                                                       ----------     ----------
                                     ASSETS
                                     ------


CURRENT ASSETS
Cash and cash equivalents                              $  710,322     $  766,277
Short term investments                                         --        505,367
Trade accounts receivable, less
     allowance for doubtful accounts of
     $55,000 and $55,000 respectively                     884,639        200,293
Inventories, net                                          659,684        426,630
Deferred tax asset                                        225,000        225,000
Prepaid expenses and other
         current assets                                   281,006        121,457
                                                       ----------     ----------

         TOTAL CURRENT ASSETS                           2,760,651      2,245,024


PROPERTY AND EQUIPMENT                                  1,345,487      1,322,443
         Less accumulated depreciation                  [738,927]      [665,913]
                                                       ----------     ----------

                  Net Property and Equipment              606,560        656,530


LONG-TERM ACCOUNTS RECEIVABLE, net                        130,000        130,000
INTANGIBLE ASSET                                          151,600        151,600
                                                       ----------     ----------


TOTAL ASSETS                                           $3,648,811     $3,183,154
                                                       ==========     ==========


                     See accompanying notes to consolidated
                         condensed financial statements.

<PAGE>


                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY

                      CONSOLIDATED CONDENSED BALANCE SHEETS
                                   (continued)


                                                           MAY 31,    NOVEMBER 30,
                                                            2008        2007
                                                         (UNAUDITED)  (AUDITED)
                                                         ----------   ----------

                      LIABILITIES AND SHAREHOLDERS' EQUITY
                      ------------------------------------


CURRENT LIABILITIES
Accounts payable                                         $  339,078   $  169,193
Accrued expenses                                            384,673      602,655
Line of credit                                              150,000           --
Current portion of capital leases                            29,604       36,435
Current portion of notes payable to related parties          21,033       66,372
Current portion of long-term debt                             8,038        8,038
                                                         ----------   ----------


TOTAL CURRENT LIABILITIES                                   932,426      882,693



Capital leases, net of current portion                       68,697       84,617
Long-term debt, net of current portion                       14,201       18,220
                                                         ----------   ----------

TOTAL LIABILITIES                                         1,015,324      985,530
                                                         ----------   ----------


SHAREHOLDERS' EQUITY
Common stock, no par value:
Authorized 9,375,000 shares
Issued and outstanding 2,103,438 shares                   8,479,854    8,479,854

Paid in capital                                             140,244      100,000
Accumulated deficit                                      [5,986,611]  [6,382,230]
                                                         ----------   ----------

         TOTAL SHAREHOLDERS' EQUITY                       2,633,487    2,197,624
                                                         ----------   ----------

         TOTAL LIABILITIES AND
         SHAREHOLDERS' EQUITY                            $3,648,811   $3,183,154
                                                         ==========   ==========


                     See accompanying notes to consolidated
                         condensed financial statements.

<PAGE>


                        WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY

                     CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
                                       (UNAUDITED)


                                            THREE MONTHS              SIX MONTHS
                                            ENDED MAY 31              ENDED MAY 31
                                         2008         2007         2008         2007
                                      ----------   ----------   ----------   ----------


NET SALES                             $1,923,280   $2,994,727   $2,636,049   $3,918,852

COST OF SALES                            849,218    1,283,227    1,088,792    1,697,106
                                      ----------   ----------   ----------   ----------

GROSS PROFIT                           1,074,062    1,711,500    1,547,257    2,221,746
                                      ----------   ----------   ----------   ----------

OPERATING EXPENSES
  Research and development                70,481       46,703      129,642       91,834
  Selling                                380,858      333,377      600,075      529,327
  General and administration             216,040      163,731      395,354      287,013
                                      ----------   ----------   ----------   ----------
  TOTAL OPERATING EXPENSES               667,379      543,811    1,125,071      908,174
                                      ----------   ----------   ----------   ----------

  Operating income                       406,683    1,167,689      422,186    1,313,572

OTHER INCOME (EXPENSE)
  Interest expense                       [4,349]      [3,579]      [6,308]      [7,684]
  Interest income                          4,321        3,526       12,841        7,187
  Other income                                --           --           --           --
                                      ----------   ----------   ----------   ----------

  Income before income taxes             406,655    1,167,636      428,719    1,313,075

Income tax benefit [Provision for
  income taxes]                         [25,000]      170,000     [33,100]      170,000
                                      ----------   ----------   ----------   ----------

  Net income                          $  381,655   $1,337,636   $  395,619   $1,483,075
                                      ==========   ==========   ==========   ==========

Basic earnings per common share       $     0.18   $     0.63   $     0.19   $     0.71
                                      ==========   ==========   ==========   ==========

Weighted average shares outstanding    2,103,438    2,103,438    2,103,438    2,103,438
                                      ==========   ==========   ==========   ==========

Diluted earnings per common share     $     0.17   $     0.58   $     0.18   $     0.65
                                      ==========   ==========   ==========   ==========

Weighted average shares, option
  and warrants outstanding             2,247,334    2,275,438    2,247,334    2,277,106
                                      ==========   ==========   ==========   ==========





                         See accompanying notes to consolidated
                             condensed financial statements.

<PAGE>


                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY

                 CONSOLIDATED CONDENSED STATEMENT OF CASH FLOWS
                                   (UNAUDITED)
                                                            SIX MONTHS ENDED
                                                           MAY 31,      MAY 31,
                                                            2008         2007
                                                         ----------   ----------

CASH FLOWS FROM OPERATING ACTIVITIES:
Net income                                               $  395,619   $1,483,075

Adjustments to reconcile net income
to net cash[used in] provided by operating activities:

Depreciation and amortization                                73,014       15,395
Interest addition on notes payable to related parties           754        6,897
Stock compensation expense                                   40,244           --
Deferred tax asset                                               --    [240,000]

Changes in Operating Assets and Liabilities:
      Increase in trade accounts receivable               [684,345]   [1,117,664]
      Increase in inventories                             [233,054]     [96,158]
      [Increase] decrease in prepaid expenses             [159,549]       17,929
      Increase in accounts payable                          169,885      346,414
      [Decrease] increase in accrued liabilities          [217,983]       47,009
                                                         ----------   ----------

Net cash [used in] provided by operating activities       [615,415]      462,897
                                                         ----------   ----------

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash from short-term investment                             505,367           --
Purchase of property and equipment                         [23,044]    [386,588]
                                                         ----------   ----------

Net cash provided by [used in] investing activities         482,323    [386,588]
                                                         ----------   ----------

CASH FLOWS FROM FINANCING ACTIVITIES:
Advance from line of credit                                 150,000           --
Payments on capital lease obligations                      [22,751]      [1,932]
Payments on notes payable and notes payable
    to related parties                                     [50,112]     [71,429]
                                                         ----------   ----------

Net cash provided by [used in] financing activities          77,137     [73,361]
                                                         ----------   ----------

[DECREASE] INCREASE IN CASH                                [55,955]        2,948

CASH AT BEGINNING OF PERIOD                                 766,277      667,196
                                                         ----------   ----------

CASH AT END OF PERIOD                                    $  710,322   $  670,144
                                                         ==========   ==========

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the year for:
      Interest                                           $    6,308        7,683
                                                         ==========   ==========
      Taxes                                              $       --   $       --
                                                         ==========   ==========


                     See accompanying notes to consolidated
                         condensed financial statements.
</TABLE>
<PAGE>

                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY

              NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS


A.    BASIS OF PRESENTATION:

The accompanying unaudited condensed interim financial statements have been
prepared by the Company pursuant to the rules and regulations of the Securities
and Exchange Commission. In the opinion of management, all adjustments (which
include only normal recurring adjustments except as noted in management's
discussion and analysis of financial condition and results of operations)
necessary to present fairly the financial position, results of operations and
changes in cash flows have been made.

Certain information and footnote disclosures normally included in financial
statements prepared in accordance with accounting principles generally accepted
in the United States of America have been condensed or omitted. It is suggested
that these consolidated financial statements be read in conjunction with the
financial statements and notes thereto included in the 2007 Annual Report on
Form 10-KSB, filed March 14, 2008. The results of operations for the quarter
ended May 31, 2008, are not necessarily indicative of the operating results for
the full year.

Inventories
-----------

Inventory, consisting of agricultural products, is stated at the lower of cost
(determined on a first-in, first-out basis) or market. The company is purchasing
larger supplies of raw materials and storing inventory due to the fact that key
raw materials are becoming more difficult to source because of shortages in
related industries.

Advertising
-----------

Advertising expense is comprised of media, agency and promotion costs.
Advertising expenses are charged to expense as incurred.

Intangible Assets
-----------------

Prior to 2002 the Company recorded formulas and processes as intangible assets,
reporting them at amortized cost, and amortizing them on a straight-line basis
over the lesser of ten years or their estimated useful lives. In 2002, the
Company adopted Statement of Financial Accounting Standards No. 142 (SFAS142),
"Goodwill and Other Intangible Assets".

Property and Equipment
----------------------

Property and equipment are recorded at cost. Depreciation is calculated on the
straight-line basis over the estimated useful lives of the depreciable assets,
or related lease life, if shorter, which range from three to ten years.
Machinery and equipment is depreciated over a five to ten year period, depending
on the type of equipment. Office furniture and fixtures is depreciated over a
five-year period and vehicles are depreciated over a three-year period.
Leasehold improvements are amortized over the life of the current lease of eight
years. Certain fixed assets are currently being purchased through capital
leases.

<PAGE>


Shipping and Handling Costs
---------------------------

The Company has historically classified income from freight charges to customers
as "Agricultural product sales". The Company classifies shipping and handling
costs in "Cost of sales". Such costs amounted to approximately $73,800 and
approximately $83,300 for the three month periods ended May 31, 2008 and May 31,
2007, respectively. Shipping and handling costs for the six month periods ended
May 31, 2008 and May 31, 2007 were approximately $103,000 and $106,200,
respectively.

Revenue Recognition
-------------------

The Company recognizes revenues from the sale of its products to customers at
the time of shipping. Products are shipped from our facility to our customers
with FOB shipping point terms at which time revenues are considered earned. The
Company will replace product which is considered "substandard", however this
occurs infrequently and the Company records a warranty accrual for these
anticipated replacements.

Research and Development
------------------------

It is the Company's policy to expense research and development costs when
incurred.

Net Income Per Share
--------------------

Basic income per common share is based upon the weighted average number of
common shares outstanding during the period. Diluted earnings per common share
is based upon the weighted average number of common shares outstanding adjusted
for the assumed conversion of dilutive stock options using the treasury stock
method.

The following is a reconciliation of the numerators and denominators of the
basic and diluted earnings per share computations for the periods presented
below:

<TABLE>
<S>            <C>
                                      Three Months Ended       Six Months Ended
                                    May 31, 2008 and 2007     May 31, 2008 and 2007
                                   -----------------------   -----------------------

Numerator for earnings
   per common share                $  381,655   $1,337,636   $  395,619   $1,483,075
                                   ----------   ----------   ----------   ----------

Denominator for basic earnings
   per common share                 2,103,438    2,103,438    2,103,438    2,103,438
                                   ----------   ----------   ----------   ----------

Effect of dilutive securities         143,896      172,000      143,896      173,668
                                   ----------   ----------   ----------   ----------

Denominator for diluted earnings
   per common share                 2,247,334    2,275,439    2,247,334    2,277,106
                                   ----------   ----------   ----------   ----------

Net income per common share:
Basic                              $     0.18   $     0.63   $     0.19   $     0.71
                                   ==========   ==========   ==========   ==========

Diluted                            $     0.17   $     0.58   $     0.18   $     0.65
                                   ==========   ==========   ==========   ==========

</TABLE>

<PAGE>


Recent Accounting Pronouncements
--------------------------------

In September 2006, the FASB issued SFAS No. 157, Defining Fair Value
Measurement. The purpose of SFAS No. 157 is to eliminate the diversity in
practice that exists due to the different definitions of fair value and the
limited guidance for applying those definitions in GAAP that are dispersed among
the many accounting pronouncements that require fair value measurements. SFAS
No. 157 is effective for financial statements issued for fiscal years beginning
after November 15, 2007, and interim periods within those fiscal years. The
Company does not believe that adoption of SFAS No. 157 will have a material
impact on its consolidated financial statements.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for
Financial Assets and Financial Liabilities - including an amendment of FASB
Statement No. 115 (SFAS No. 159). SFAS No. 159 expands opportunities to use fair
value measurements in financial reporting and permits entities to choose to
measure many financial instruments and certain other items at fair value. Upon
adoption of SFAS No. 159, an entity may elect the fair value option for eligible
items that exist at the adoption date. Subsequent to the initial adoption, the
election of the fair value option should only be made at initial recognition of
the asset or liability or upon a re-measurement event that gives rise to
new-basis accounting. SFAS No. 159 does not affect any existing accounting
literature that requires certain assets and liabilities to be carried at fair
value nor does it eliminate disclosure requirements included in other accounting
standards. This Statement is effective as of the beginning of an entity's first
fiscal year that begins after November 15, 2007. Early adoption is permitted as
of the beginning of a fiscal year that begins on or before November 15, 2007,
provided the entity also elects to apply the provisions of FASB Statement No.
157, Fair Value Measurements. The Company does not believe that the adoption of
SFAS No. 159 will have a material impact on its consolidated financial
statements.

In December 2007, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 141(R), "Business Combinations" (hereafter
"SFAS No. 141(R)"). This statement is to improve the relevance, representational
faithfulness, and comparability of the information that a reporting entity
provides in its financial reports about a business combination and its effects.
It is effective for business combinations for which the acquisition date is on
or after the beginning of the first annual reporting period beginning on or
after December 15, 2008. The Company does not believe that adoption of SFAS No.
141(R) will have a material impact on its consolidated financial statements.

In December 2007, the FASB issued FASB Statement No. 160 "Non-controlling
Interests in Consolidated Financial Statements - an amendment of ARB No. 51"
("SFAS No. 160"), which causes non-controlling interests in subsidiaries to be
included in the equity section of the balance sheet. SFAS No. 160 applies
prospectively to business combinations for which the acquisition date is on or
after the beginning of the first annual reporting period beginning on or after
December 15, 2008, except for the presentation and disclosure requirements,
which shall be applied retrospectively for all periods presented. The Company
does not believe that adoption of SFAS No. 160 will have a material impact on
its consolidated financial statements.

<PAGE>


In December 2007, the FASB issued FASB Statement No. 161 "Disclosures about
Derivative Instruments and Hedging Activities-an amendment of FASB Statement No.
133" ("SFAS No. 161"), changes the disclosure requirements for derivative
instruments and hedging activities. Entities are required to provide enhanced
disclosures about (a) how and why an entity uses derivative instruments, (b) how
derivative instruments and related hedged items are accounted for under
Statement 133 and its related interpretations, and (c) how derivative
instruments and related hedged items affect an entity's financial position,
financial performance, and cash flows. SFAS No. 160 is effective for financial
statements issued for fiscal years and interim periods beginning after November
15, 2008, with early application encouraged. This Statement encourages, but does
not require, comparative disclosures for earlier periods at initial adoption.
The Company does not believe that adoption of SFAS No. 161 will have a material
impact on its consolidated financial statements.

Long Lived Assets
-----------------

The Company investigates potential impairments of its long-lived assets on an
individual basis when evidence exists that events or changes in circumstances
may have made recovery of an asset's carrying value unlikely. An impairment loss
is recognized when the sum of the expected undiscounted future net cash flows is
less than the carrying amount of the asset. No such losses have been identified.

Stock Based Compensation
------------------------

Prior to December 1, 2006, the Company accounted for stock option awards granted
under the Company's share-based payment plans in accordance with the recognition
and measurement provisions of Accounting Principles Board Opinion No. 25,
ACCOUNTING FOR STOCK ISSUED TO EMPLOYEES, ("APB 25") and related
Interpretations, as permitted by Statement of Financial Accounting Standards
("SFAS") No. 123, ACCOUNTING FOR STOCK-BASED COMPENSATION, ("SFAS 123").
Share-based employee compensation expense was not recognized in the Company's
consolidated statements of earnings prior to December 1, 2006, as all stock
option awards granted under the plans had an exercise price equal to or greater
than the market value of the common stock on the date of the grant. Effective
December 1, 2006, the Company adopted the provisions of SFAS No. 123R (revised
2004), SHARE-BASED PAYMENT, ("SFAS 123R") using the
modified-prospective-transition method. In accordance with the
modified-prospective-transition method, results for prior periods have not been
restated. The adoption of SFAS 123R resulted in a decrease to net earnings of
approximately $40,000 for the three and six months ended May 31, 2008.


<PAGE>


B.       MATERIAL SUBSEQUENT EVENTS AND CONTINGENCIES:

              None


C.       SIGNIFICANT EQUITY INVESTEES:

              None

D.       SIGNIFICANT DISPOSITIONS AND PURCHASE BUSINESS COMBINATIONS:

              None

E.       MATERIAL ACCOUNTING CHANGES:

             None

F.       DEVELOPMENT STAGE COMPANIES:

                  Not Applicable


                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY

                      MANAGEMENT'S DISCUSSION AND ANALYSIS

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS.

      The following discussion and analysis provides information that we believe
is relevant to an assessment and understanding of our results of operations and
financial condition. You should read this analysis in conjunction with our
consolidated financial statements and related footnotes. This discussion and
analysis contains forward-looking statements relating to future events and our
future financial performance. The statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results to be
materially different from those results expressed or implied by these
forward-looking statements, including those set forth in this Quarterly Report.

RESULTS OF OPERATIONS:

      Net sales for the three month period ended May 31, 2008 were $1,923,280,
representing a 36% decrease from the same period in the prior year. For the six
month period ended May 31, 2008, sales were $2,636,049 and represents a decrease
of 33% from the prior year's sales of $3,918,852. These decreases are primarily
due to the loss of one of the Company's high nitrogen products and continued
cold weather in many of the Company's key markets during the first two quarters
of fiscal 2008.

      Cost of sales as a percentage of net sales increased to 44% for the
quarter ended May 31, 2008 as compared with 43% for the same period in the prior
year. For the six month period ended May 31, 2008, cost of sales as a percentage
of net sales decreased to 41% from 43% for the six month period ended May
31,2007. Raw material expenses have increased due to raw material shortages and
increased freight charges. It is anticipated such costs will continue to
increase for the foreseeable future.

<PAGE>

      Operating expenses for the three and six month periods ended May 31, 2008
increased 23% and 24%, respectively, compared with the same periods in the prior
year. These increases are primarily related to selling and general and
administrative expenses as discussed below.

      Research and development expenses for the three and six month periods
ended May 31, 2008 increased 51% and 41%, respectively, compared with the same
periods in the prior year. These increases are primarily due to increased
salaries with the addition of a full-time lab technician, an increase in lab
supplies, and increases in contract research associated with trials on potential
new products.

      Selling expenses for the three and six month periods ended May 31, 2008
increased 14% to $380,858 and increased 13% to $600,075, respectively compared
with the same periods in the prior year. These increases are primarily due to
increases in salary expense, commission expense and travel expenses related to
the addition of two new sales representatives for parts of California and for
the Great Lakes region. In addition, part of the increase is due to the
recognition of stock compensation expense issued to employees in the sales
department.

      General and administrative expenses for the three and six month periods
ended May 31, 2008 increased by $52,309 or 32%, and $108,341 or 38%,
respectively, when compared with the same periods in the prior year. These
increases are primarily due to increased salaries, increased amortization
associated with the tenant improvements at the Company's new facility and stock
compensation expense to employees in the general and administrative department.

      Net income for the quarter ended May 31, 2008 was $381,655 as compared
with net income of $1,337,636, for the same period in the prior year. Net income
for the six month period ended May 31, 2008 was $395,619 as compared with net
income of $1,483,075 in the prior year. As a result, basic earnings per share
decreased to $.19 for the six months ended May 31, 2008 compared with $.71 per
share for the six months ended May 31, 2007.

      The Company had over $1 million of federal net operating loss
carryforwards at November 30, 2007, which it is currently utilizing to reduce
its income tax exposure. Management has provided for the annual minimum
California Franchise Tax. In addition, management has assessed the recoverable
value of its current deferred tax asset at $225,000 as the Company has been able
to achieve its budgeted targets and the Company expects to utilize these
benefits in the current 24 months. The Company has limited its deferred tax
asset to its expected rolling two year utilization rate taking into
consideration its expected expansion of both sales and costs associated with
increased production and sales force, or until utilized, whichever occurs first.


<PAGE>


                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY

                      MANAGEMENT'S DISCUSSION AND ANALYSIS


LIQUIDITY AND CAPITAL RESOURCES:

      Working capital was $1,828,225 at May 31, 2008, an increase of $465,894,
from $1,362,331 at November 30, 2007.

      The Company has a $500,000 line of credit available to be drawn down if
required of which, $150,000 has been drawn through May 31, 2008. This Line of
Credit is secured by all the assets of the Company.

      The Company's principal executive office is located at 1260 Avenida
Chelsea, Vista, California, 92081. This facility consists of 19,504 square feet
and is used for offices, a laboratory and the production and storage of
agricultural products and materials. The Company leases these facilities under a
lease that expires in January, 2015. Rent is being expensed on a straight-line
basis over the term of the lease. The lease commenced on January 1, 2007 and has
a term of eight (8) years. WAP has an option to extend the term for an
additional three (3) years at the fair market rate at the time of extension. The
rent under the lease for the initial year is approximately $13,650 per month,
with increases by three percent (3%) each year. WAP must also pay certain other
customary expenses under the lease.

      The Company remained under lease at the Joshua Way location until March
31, 2008. The Company used the Joshua Way location for several months following
the commencement of the new lease to facilitate the transition to the new leased
premises and the continuation of their business without significant
interruption. The Company continues to use the Joshua Way facility for storage
on a month to month basis until the landlord installs a new tenant or the
Company no longer needs the storage whichever comes first.

IMPACT OF INFLATION

      The Company does not believe inflation has had a significant effect on its
operations.

ITEM 3.  CONTROLS AND PROCEDURES.

The Company's management evaluated, with the participation of the Company's
principal executive and principal financial officer, the effectiveness of the
Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and
15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange
Act")), as of May 31, 2008. Based on this evaluation, the Company's principal
executive and principal financial officer concluded that the Company's
disclosure controls and procedures were effective as of May 31, 2008.

There has been no change in the Company's internal control over financial
reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act)
that occurred during the Company's fiscal quarter ended May 31, 2008, that has
materially affected, or is reasonably likely to materially affect, the Company's
internal control over financial reporting.

<PAGE>



PART II - OTHER INFORMATION


ITEM 1.  LEGAL PROCEEDINGS
                  None

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
                  None

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES
                  None

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
                  None

ITEM 5.  OTHER INFORMATION
                  None

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

      A.    EXHIBITS

            31.1 Certification of the Principal Executive Officer and Principal
            Financial Officer Pursuant to Rule 13a-14 or 15d-14 of the Exchange
            Act pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

            31.2 Certification of Principal Executive Officer and Principal
            Financial Officer Pursuant to 18 U.S.C. Section 1350 as adopted
            pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


      B.    REPORTS ON FORM 8-K

            Form 8-K, filed on June 26, 2008, disclosing the amended Employment
            Agreement by and between Company and Christine Koenemann.

<PAGE>



                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY


         SIGNATURES

      In accordance with the requirements of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.



                                              WESTBRIDGE RESEARCH GROUP
                                              (Registrant)

                                              /s/ Christine Koenemann
                                              ----------------------------------
                                              Christine Koenemann, President
                                              Principal Executive Officer
                                              Principal Financial Officer



Date:  July 15, 2008